資本剰余金、研究開発費 - 化成品事業、繰延税金資産他2件
- 【期間】
| 年度 | 資本剰余金 | 研究開発費 - 化成品事業 | 繰延税金資産 | 当期変動額合計 | 受取手形 |
|---|
| 2007/03 | 81.2億 | | - | | - | | - | | - | |
| 2008/03 | 81.2億 | -0% | - | | 14.8億 | | -1百万 | | 65.2億 | |
| 2009/03 | 81.2億 | ±0% | - | | 16億 | +8.5% | - | | 44億 | -32.6% |
| 2010/03 | 81.2億 | ±0% | - | | 14.3億 | -10.7% | - | | 36億 | -18.1% |
| 2011/03 | 81.2億 | ±0% | - | | 15.1億 | +5.2% | - | | 32.3億 | -10.3% |
| 2012/03 | 81.2億 | ±0% | - | | 16.8億 | +11.6% | - | | 35.7億 | +10.5% |
| 2013/03 | 81.2億 | ±0% | - | | 14.3億 | -15.1% | - | | 30億 | -15.9% |
| 2014/03 | 81.2億 | ±0% | - | | 17.2億 | +20.4% | - | | 19.9億 | -33.7% |
| 2015/03 | 81.2億 | ±0% | - | | 16.7億 | -3% | - | | 15.4億 | -22.5% |
| 2016/03 | 81.2億 | ±0% | - | | 14.2億 | -15.1% | - | | 12.9億 | -16.1% |
| 2017/03 | 81.2億 | ±0% | - | | 12.5億 | -12% | - | | 13.8億 | +6.4% |
| 2018/03 | 81.1億 | -0.1% | - | | 13.3億 | +7% | - | | 19.5億 | +41.7% |
| 2019/03 | 81.1億 | ±0% | 42.6億 | | - | | - | | 17.8億 | -9% |
| 2020/03 | 81.1億 | ±0% | 45.1億 | +6% | - | | - | | 11.3億 | -36.3% |
| 2021/03 | 81.1億 | ±0% | 45億 | -0.3% | - | | - | | 11.6億 | +2.2% |
| 2022/03 | 81.1億 | ±0% | 44.9億 | -0.2% | - | | - | | 63.3億 | +448.1% |
| 2023/03 | 81.1億 | ±0% | 48.5億 | +8.1% | - | | - | | 66.9億 | +5.7% |
| 2024/03 | 81.1億 | ±0% | - | | - | | - | | - | |
